Market revenue in 2023 | USD 102.2 million |
Market revenue in 2030 | USD 215.8 million |
Growth rate | 11.3% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceuticals |
Fastest growing segment | Other Products |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pharmaceuticals, Vaccines, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services, Other Products |
Key market players worldwide | Zoetis, Boehringer Ingelheim, CEVA Inc, Merck & Co Inc, Esaote, Vetoquinol SA, IDEXX Laboratories Inc, Dechra Veterinary Products, Sound, Hallmarq Veterinary Imaging |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to equine healthcare market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 27.59% in 2023. Horizon Databook has segmented the Japan equine healthcare market based on pharmaceuticals, vaccines, medicinal feed additives, orthobiologics, diagnostics, software & services, other products covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan equine healthcare market, including forecasts for subscribers. This country databook contains high-level insights into Japan equine healthcare market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account